Therapies targeting CDK4/6 cause regression, immune cell activation, and sensitization to PD-L1 immunotherapy in pancreatic neuroendocrine tumors

Courtney Kaemmer; Shaikamjad Umesalma; Chandra Maharjan; Jordan Kohlmeyer; Joshua Lingo; Emily Wilkerson; Ryan Sheehy; Mariah Leidinger; David Meyerholz; Sarah Bell; Gideon Zamba; Patrick Breheny; Edmund Lattime; Chandrikha Chandrasekharan; Andrew Bellizzi; Laura Herring; Lee Graves; Benjamin Darbro; Ziqiang Yuan; Steven Libutti; Dawn Quelle

doi:10.1530/endoabs.98.B28

Abstract

Therapies targeting CDK4/6 cause regression, immune cell activation, and sensitization to PD-L1 immunotherapy in pancreatic neuroendocrine tumors

Courtney Kaemmer, Shaikamjad Umesalma, Chandra Maharjan, Jordan Kohlmeyer, Joshua Lingo, Emily Wilkerson, Ryan Sheehy, Mariah Leidinger, David Meyerholz, Sarah Bell, …

Endocrine Abstracts, Vol.98, p.B28

12/15/2023

DOI: 10.1530/endoabs.98.B28

View Online

Abstract

Abstract only

Details

Title: Subtitle: Therapies targeting CDK4/6 cause regression, immune cell activation, and sensitization to PD-L1 immunotherapy in pancreatic neuroendocrine tumors
Creators: Courtney Kaemmer
Shaikamjad Umesalma
Chandra Maharjan
Jordan Kohlmeyer
Joshua Lingo
Emily Wilkerson
Ryan Sheehy
Mariah Leidinger
David Meyerholz
Sarah Bell
Gideon Zamba
Patrick Breheny
Edmund Lattime
Chandrikha Chandrasekharan
Andrew Bellizzi
Laura Herring
Lee Graves
Benjamin Darbro
Ziqiang Yuan
Steven Libutti
Dawn Quelle
Resource Type: Abstract
Publication Details: Endocrine Abstracts, Vol.98, p.B28
DOI: 10.1530/endoabs.98.B28
ISSN: 1479-6848
eISSN: 1479-6848
Language: English
Date published: 12/15/2023
Academic Unit: Neuroscience and Pharmacology; Biostatistics; Hematology, Oncology, and Blood & Marrow Transplantation; Stead Family Department of Pediatrics; Internal Medicine; Pathology; Radiology; Medical Genetics and Genomics
Record Identifier: 9984539443902771

Metrics

4 Record Views